Study to see if third COVID-19 vaccine dose protects kidney transplant recipients
Johns Hopkins University in Baltimore will enroll up to 200 adults who received a kidney transplant in the past year and had no or low antibody response to two doses of the Moderna or Pfizer COVID-19 vaccine in a study to see if a third dose of the vaccine induces a protective immune response, the National Institutes of Health announced today.
Preliminary results are expected next month. The findings will inform a subsequent larger phase of the trial that includes higher-risk strategies to induce a protective immune response against SARS-CoV-2 in organ transplant recipients who do not respond to a third vaccine dose, NIH said.
Related News Articles
Headline
The Department of Health and Human Services June 30 announced it will terminate emergency use authorization declarations for certain drugs and medical devices…
Headline
The Centers for Disease Control and Prevention Feb. 19 released a report on the low use of COVID-19 antiviral drugs among individuals age 65 and older, a…
Headline
The Centers for Disease Control and Prevention Dec. 11 released a report that found last year’s version of the COVID-19 vaccine was 76% effective in preventing…
Headline
The Advisory Committee on Immunization Practices Sept. 19 recommended that patients should consult their health care provider if they want to receive a COVID-…
Headline
The Food and Drug Administration July 10 approved Moderna’s Spikevax COVID-19 vaccine for children under 12 with at least one underlying condition that…
Headline
Department of Health and Human Services Secretary Robert F. Kennedy Jr. May 27 announced in a post on X that the Centers for Disease Control and Prevention…